The Prognostic Value of Preoperative Serum Tumor Markers in Non-Small Cell Lung Cancer Varies With Radiological Features and Histological Types
Authors:
Open Access
- 11 June 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 11
Abstract
Objectives: To assess the association between common-used serum tumor markers and recurrence of lung adenocarcinoma and squamous cell carcinoma separately and determine the prognostic value of serum tumor markers in lung adenocarcinoma featured as ground glass opacities. Methods: A total of 2,654 non-small cell lung cancer patients undergoing surgical resection between January 2008 and September 2014 were analyzed. The serum levels of carcinoma embryonic antigen (CEA), cytokeratin 19 fragment (CYFRA21-1), neuron-specific enolase (NSE), carbohydrate antigen 125 (CA125), carbohydrate antigen 153 (CA153) and carbohydrate antigen 199 (CA199) were tested preoperatively. Survival analyses were performed with COX proportional hazard regression. Results: Among patients with lung adenocarcinoma, elevated preoperative serum CEA(HR=1.246, 95%CI:1.043-1.488, P=0.015), CYFRA21-1(HR=1.209, 95%CI:1.015-1.441, P=0.034) and CA125(HR=1.361, 95%CI:1.053-1.757, P=0.018) were significantly associated with poorer recurrence free survival (RFS). Elevated preoperative serum CA199 predicted worse RFS in patients diagnosed with lung squamous cell carcinoma (HR=1.833, 95%CI: 1.216-2.762, P=0.004). Preoperative serum CYFRA21-1(HR=1.256, 95%CI:1.044-1.512, P=0.016) and CA125(HR=1.373, 95%CI: 1.050-1.795, P=0.020) were independent prognostic factors for patients with adenocarcinoma presenting as solid nodules while serum CEA (HR=2.160,95%CI:1.311-3.558, P=0.003) and CA125(HR=2.475,95%CI:1.163-5.266, P=0.019) were independent prognostic factors for patients with adenocarcinoma featured as ground glass opacities. Conclusions: The prognostic significances of preoperative serum tumor markers in non-small cell lung cancer were associated with radiological features and histological types.Keywords
This publication has 58 references indexed in Scilit:
- Prognostic Value of Tumor Markers, NSE, CA125 and SCC, in Operable NSCLC PatientsInternational Journal of Molecular Sciences, 2013
- Comprehensive genomic characterization of squamous cell lung cancersNature, 2012
- A Prospective Radiological Study of Thin-Section Computed Tomography to Predict Pathological Noninvasiveness in Peripheral Clinical IA Lung Cancer (Japan Clinical Oncology Group 0201)Journal of Thoracic Oncology, 2011
- Preoperative CYFRA 21-1 levels as a prognostic factor in c-stage I non-small cell lung cancerEuropean Journal of Cardio-Thoracic Surgery, 2007
- Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancerEuropean Journal of Cardio-Thoracic Surgery, 2007
- Clinical value of p53, c‐erbB‐2, CEA and CA125 regarding relapse, metastasis and death in resectable non‐small cell lung cancerInternational Journal of Cancer, 2003
- Serum carcinoembryonic antigen as an adjunct to preoperative staging of lung cancerThe Journal of Thoracic and Cardiovascular Surgery, 1998
- Prognostic value of pretreatment CEA, SCC-Ag and CA 19–9 levels in sera of patients with non-small cell lung cancerEuropean Journal Of Cancer Prevention, 1992
- CEA in tumors of other than colorectal originSeminars in Surgical Oncology, 1991
- Comparison of a new tumour marker, CA 19-9, with alpha-fetoprotein and carcinoembryonic antigen in patients with upper gastrointestinal diseases.Journal of Clinical Pathology, 1984